Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Maecke · SciRah

Researcher profile · Semantic Scholar

H. Maecke

Share profile

H. Maecke — researcher profile on SciRah

h-index: 53
Works: 204
Citations: 9,345

Most-cited papers

Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
M. Fani, H. Maecke, S. Okarvi
2012Theranostics319 citations Open access
Semantic Scholar
PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference
M. Fani, Luigi Del Pozzo, K. Abiraj, R. Mansi +6 more
2011Journal of Nuclear Medicine254 citations
Semantic Scholar
Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study
D. Wild, M. Fani, R. Fischer, Luigi Del Pozzo +6 more
2014Journal of Nuclear Medicine253 citations Open access
Semantic Scholar
Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT Within Patients with Gastroenteropancreatic Neuroendocrine Tumors
D. Wild, J. Bomanji, Pascal Benkert, H. Maecke +3 more
2013Journal of Nuclear Medicine203 citations Open access
Semantic Scholar
Radiopeptide Imaging and Therapy in Europe
V. Ambrosini, M. Fani, S. Fanti, F. Forrer +1 more
2011Journal of Nuclear Medicine193 citations Open access
Semantic Scholar
First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
D. Wild, M. Fani, M. Béhé, I. Brink +4 more
2011Journal of Nuclear Medicine186 citations Open access
Semantic Scholar
Unexpected Sensitivity of sst2 Antagonists to N-Terminal Radiometal Modifications
M. Fani, Friederike Braun, B. Waser, Karin Beetschen +6 more
2012Journal of Nuclear Medicine161 citations Open access
Semantic Scholar
Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men
Gesche Wieser, R. Mansi, A. Grosu, W. Schultze-Seemann +5 more
2014Theranostics147 citations Open access
Semantic Scholar
Novel 64Cu- and 68Ga-Labeled RGD Conjugates Show Improved PET Imaging of ανβ3 Integrin Expression and Facile Radiosynthesis
R. Dumont, F. Deininger, R. Haubner, H. Maecke +2 more
2011Journal of Nuclear Medicine139 citations Open access
Semantic Scholar
Alpha- versus beta-particle radiopeptide therapy in a human prostate cancer model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN).
D. Wild, Michael Frischknecht, Hanwen Zhang, A. Morgenstern +5 more
2011Cancer Research125 citations Open access
Semantic Scholar
Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment
H. Maecke, J. Reubi
2011Journal of Nuclear Medicine122 citations Open access
Semantic Scholar
Bombesin Antagonist–Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor–Positive Tumors
K. Abiraj, R. Mansi, M. Tamma, M. Fani +5 more
2011Journal of Nuclear Medicine116 citations Open access
Semantic Scholar
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist 68Ga-RM2 And PET
C. Stoykow, T. Erbes, H. Maecke, S. Bulla +9 more
2016Theranostics106 citations Open access
Semantic Scholar
Somatostatin Receptor–Targeted Radiopeptide Therapy with 90Y-DOTATOC and 177Lu-DOTATOC in Progressive Meningioma: Long-Term Results of a Phase II Clinical Trial
Nicolas Marincek, Piotr Radojewski, R. Dumont, P. Brunner +4 more
2015Journal of Nuclear Medicine90 citations Open access
Semantic Scholar
Targeted Radiotherapy of Prostate Cancer with a Gastrin-Releasing Peptide Receptor Antagonist Is Effective as Monotherapy and in Combination with Rapamycin
R. Dumont, M. Tamma, Friederike Braun, S. Borkowski +4 more
2013Journal of Nuclear Medicine86 citations Open access
Semantic Scholar
Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
G. Nicolas, S. Beykan, H. Bouterfa, J. Kaufmann +7 more
2017Journal of Nuclear Medicine78 citations Open access
Semantic Scholar
Imaging Expression of the Human Somatostatin Receptor Subtype-2 Reporter Gene with 68Ga-DOTATOC
Hanwen Zhang, Maxim A. Moroz, I. Serganova, T. Ku +6 more
2011Journal of Nuclear Medicine67 citations Open access
Semantic Scholar
The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors
P. Brunner, Ann-Catherine Jörg, K. Glatz, L. Bubendorf +12 more
2017European Journal of Nuclear Medicine and Molecular Imaging63 citations Open access
Semantic Scholar
90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
Karine Gerster-Gilliéron, F. Forrer, H. Maecke, J. Mueller-Brand +2 more
2015Journal of Nuclear Medicine60 citations Open access
Semantic Scholar
Hybrid bombesin analogues: combining an agonist and an antagonist in defined distances for optimized tumor targeting.
Carsten Kroll, R. Mansi, Friederike Braun, Stefanie Dobitz +2 more
2013Journal of the American Chemical Society58 citations
Semantic Scholar
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
E. Gourni, Coline Canovas, V. Goncalves, F. Denat +2 more
2015PLoS ONE55 citations Open access
Semantic Scholar
N-Terminal Modifications Improve the Receptor Affinity and Pharmacokinetics of Radiolabeled Peptidic Gastrin-Releasing Peptide Receptor Antagonists: Examples of 68Ga- and 64Cu-Labeled Peptides for PET Imaging
E. Gourni, R. Mansi, Mazen Jamous, B. Waser +5 more
2014Journal of Nuclear Medicine54 citations Open access
Semantic Scholar
In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
M. Fani, M. Tamma, G. Nicolas, Elisabeth Lasri +5 more
2012Molecular Pharmaceutics54 citations
Semantic Scholar
Copper-64 Labeled Macrobicyclic Sarcophagine Coupled to a GRP Receptor Antagonist Shows Great Promise for PET Imaging of Prostate Cancer.
E. Gourni, Luigi Del Pozzo, Emilie Kheirallah, C. Smerling +6 more
2015Molecular Pharmaceutics51 citations
Semantic Scholar
PEG spacers of different length influence the biological profile of bombesin-based radiolabeled antagonists.
Mazen Jamous, M. Tamma, E. Gourni, B. Waser +3 more
2014Nuclear Medicine and Biology51 citations
Semantic Scholar
Radioimmunotherapy with 177Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas
F. Forrer, C. Oechslin-Oberholzer, B. Campana, R. Herrmann +3 more
2013Journal of Nuclear Medicine51 citations Open access
Semantic Scholar
Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor.
P. Kolenc-Peitl, R. Mansi, M. Tamma, T. Gmeiner-Stopar +5 more
2011Journal of Medicinal Chemistry50 citations Open access
Semantic Scholar
Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors
Hanwen Zhang, K. Abiraj, D. Thorek, B. Waser +4 more
2012PLoS ONE47 citations Open access
Semantic Scholar
Radiolabeled Bicyclic Somatostatin-Based Analogs: A Novel Class of Potential Radiotracers for SPECT/PET of Neuroendocrine Tumors
M. Fani, Andreas Mueller, M. Tamma, G. Nicolas +4 more
2010Journal of Nuclear Medicine47 citations Open access
Semantic Scholar
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients
T. Maina, M. Konijnenberg, Petra KolencPeitl, P. Garnuszek +11 more
2016European Journal of Pharmaceutical Sciences44 citations Open access
Semantic Scholar
The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model
S. Rylova, C. Stoykow, Luigi Del Pozzo, K. Abiraj +4 more
2018PLoS ONE43 citations Open access
Semantic Scholar
Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand Applications
J. Reubi, H. Maecke
2017Journal of Nuclear Medicine40 citations Open access
Semantic Scholar
Immuno-PET Imaging of CD30-Positive Lymphoma Using 89Zr-Desferrioxamine–Labeled CD30-Specific AC-10 Antibody
S. Rylova, Luigi Del Pozzo, C. Klingeberg, Roswitha Tönnesmann +4 more
2016Journal of Nuclear Medicine38 citations Open access
Semantic Scholar
Radiopharmaceuticals for somatostatin receptor imaging.
R. Mikołajczak, H. Maecke
2016Nuclear medicine review. Central & Eastern Europe37 citations Open access
Semantic Scholar
The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging—First Preclinical Studies
E. Gourni, B. Waser, P. Clerc, D. Fourmy +2 more
2014Journal of Nuclear Medicine36 citations Open access
Semantic Scholar
New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities.
S. Poty, Pauline Désogère, C. Goze, F. Boschetti +6 more
2015Dalton Transactions35 citations Open access
Semantic Scholar
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial
D. Pawlak, C. Rangger, P. Peitl, P. Garnuszek +10 more
2016European Journal of Pharmaceutical Sciences34 citations Open access
Semantic Scholar
Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
K. Abiraj, R. Mansi, M. Tamma, F. Forrer +4 more
2010Chemistry34 citations
Semantic Scholar
AMD3100: A Versatile Platform for CXCR4 Targeting (68)Ga-Based Radiopharmaceuticals.
S. Poty, E. Gourni, Pauline Désogère, F. Boschetti +3 more
2016Bioconjugate chemistry31 citations
Semantic Scholar
Survival after somatostatin based radiopeptide therapy with (90)Y-DOTATOC vs. (90)Y-DOTATOC plus (177)Lu-DOTATOC in metastasized gastrinoma.
R. Dumont, D. Seiler, Nicolas Marincek, P. Brunner +6 more
2015American Journal of Nuclear Medicine and Molecular Imaging28 citations
Semantic Scholar
Radioiodinated Exendin-4 Is Superior to the Radiometal-Labelled Glucagon-Like Peptide-1 Receptor Probes Overcoming Their High Kidney Uptake
T. Läppchen, Roswitha Tönnesmann, J. Eersels, P. Meyer +2 more
2017PLoS ONE26 citations Open access
Semantic Scholar
Evaluation of three different families of bombesin receptor radioantagonists for targeted imaging and therapy of gastrin releasing peptide receptor (GRP-R) positive tumors.
R. Mansi, K. Abiraj, Xue-Juan Wang, M. Tamma +5 more
2015Journal of Medicinal Chemistry26 citations
Semantic Scholar
Stereochemistry of amino acid spacers determines the pharmacokinetics of (111)In-DOTA-minigastrin analogues for targeting the CCK2/gastrin receptor.
Petra Kolenc Peitl, M. Tamma, M. Krošelj, Friederike Braun +5 more
2015Bioconjugate chemistry25 citations
Semantic Scholar
Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study
Nicolas Marincek, Ann-Catherine Jörg, P. Brunner, C. Schindler +6 more
2013Journal of Translational Medicine25 citations Open access
Semantic Scholar
Approaches to Improve the Pharmacokinetics of Radiolabeled Glucagon-Like Peptide-1 Receptor Ligands Using Antagonistic Tracers
S. Rylova, B. Waser, Luigi Del Pozzo, Roswitha Tönnesmann +4 more
2016Journal of Nuclear Medicine21 citations Open access
Semantic Scholar
A novel CCK2/gastrin receptor-localizing radiolabeled peptide probe for personalized diagnosis and therapy of patients with progressive or metastatic medullary thyroid carcinoma: a multicenter phase I GRAN-T-MTC study
P. Erba, H. Maecke, R. Mikołajczak, C. Decristoforo +20 more
2017Polish Archives of Internal Medicine20 citations Open access
Semantic Scholar
Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT
K. Michalski, K. Laubner, C. Stoykow, M. Omrane +5 more
2020Clinical Nuclear Medicine18 citations
Semantic Scholar
Accuracy of [68Ga]Ga-RM2-PET/CT for diagnosis of primary prostate cancer compared to histopathology.
T. Fassbender, F. Schiller, M. Mix, H. Maecke +4 more
2019Nuclear Medicine and Biology18 citations Open access
Semantic Scholar
Approaches to improve metabolic stability of a statine-based GRP receptor antagonist.
I. Popp, Luigi Del Pozzo, B. Waser, J. Reubi +3 more
2017Nuclear Medicine and Biology17 citations
Semantic Scholar
Radiochemistry and Preclinical PET Imaging of 68Ga-Desferrioxamine Radiotracers Targeting Prostate-Specific Membrane Antigen
E. Gourni, Luigi Del Pozzo, Mark D. Bartholomä, Y. Kiefer +3 more
2017Molecular Imaging17 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Reubi×24
Invite
J. Reubi — researcher profile on SciRah
R. Mansi×13
Invite
R. Mansi — researcher profile on SciRah
M. Fani×12
Invite
M. Fani — researcher profile on SciRah
M. Tamma×11
Invite
M. Tamma — researcher profile on SciRah

×11

Invite

B. Waser — researcher profile on SciRah

Invite

P. Meyer — researcher profile on SciRah

Invite

W. Weber — researcher profile on SciRah

Invite

E. Gourni — researcher profile on SciRah

Luigi Del Pozzo×8

Invite

Luigi Del Pozzo — researcher profile on SciRah

Invite

K. Abiraj — researcher profile on SciRah

Invite

R. Cescato — researcher profile on SciRah

Invite

D. Wild — researcher profile on SciRah